FDA begins process to remove breast cancer indication from Avastin label
- Details
- Category: FDA
![The U.S. Food and Drug Administration The U.S. Food and Drug Administration](/images/stories/logo/fda.gif)
European Medicines Agency and ENCePP launch electronic Register of Studies
- Details
- Category: EMA
![The European Medicines Agency The European Medicines Agency](/images/stories/logo/ema.gif)
FDA warns consumers not to use Vigor-25
- Details
- Category: FDA
![The U.S. Food and Drug Administration The U.S. Food and Drug Administration](/images/stories/logo/fda.gif)
FDA: Include warnings on risk for class of prostate cancer drugs
- Details
- Category: FDA
![The U.S. Food and Drug Administration The U.S. Food and Drug Administration](/images/stories/logo/fda.gif)
FDA: Possible increased risk of thigh bone fracture with bisphosphonates
- Details
- Category: FDA
![The U.S. Food and Drug Administration The U.S. Food and Drug Administration](/images/stories/logo/fda.gif)
FDA issues final rule on safety information during clinical trials
- Details
- Category: FDA
![The U.S. Food and Drug Administration The U.S. Food and Drug Administration](/images/stories/logo/fda.gif)
European Medicines Agency and U.S. Food and Drug Administration extend confidentiality arrangements
- Details
- Category: EMA
![The European Medicines Agency The European Medicines Agency](/images/stories/logo/ema.gif)
More Pharma News ...
- Forest Pharmaceuticals agrees to guilty plea for violating FDA laws
- European Medicines Agency holds international workshop on clinical trials
- European Medicines Agency starts review of Pandemrix
- FDA Proposes Withdrawal of Low Blood Pressure Drug
- EMA and US FDA seek potential candidate companies for joint GMP inspection programme
- European Medicines Agency starts review of rosiglitazone-containing medicines
- FDA to Communicate Safety Monitoring Activities to Consumers and Health Care Professionals